Changeflow GovPing Healthcare & Life Sciences Lymphatic System Drug Delivery Patent EP3801464A1
Routine Notice Added Final

Lymphatic System Drug Delivery Patent EP3801464A1

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3801464A1 titled 'Drug Delivery Methods Targeting the Lymphatic System' on April 15, 2026. The patent applicant is Vivasor, Inc., with inventor Russell Frederick ROS, and covers IPC classifications A61K 9/00, A61M 37/00, A61P 35/00, and A61P 35/04. The designated states include all EPC contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 32 changes logged to date.

What changed

The European Patent Office published patent application EP3801464A1, a drug delivery method targeting the lymphatic system filed by Vivasor, Inc. The invention is classified under A61K 9/00 (medicinal preparations), A61M 37/00 (implantable drug delivery systems), A61P 35/00 (antineoplastic agents), and A61P 35/04 (antineoplastic agents for metastasis treatment), indicating therapeutic applications for cancer treatment via lymphatic targeting.

Competitors in the drug delivery or oncology space should review this publication to assess potential freedom-to-operate implications, particularly for lymphatic-targeted therapeutic platforms. While patent publications do not create immediate compliance obligations, they signal active IP activity in the lymphatic drug delivery space that may inform R&D and partnering strategies.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DRUG DELIVERY METHODS TARGETING THE LYMPHATIC SYSTEM

Publication EP3801464A1 Kind: A1 Apr 15, 2026

Applicants

Vivasor, Inc.

Inventors

ROSS, Russell Frederick

IPC Classifications

A61K 9/00 20060101AFI20220204BHEP A61M 37/00 20060101ALI20220204BHEP A61P 35/00 20060101ALI20220204BHEP A61P 35/04 20060101ALI20220204BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Medical device makers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent publication Drug delivery systems Oncology therapeutics
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!